Medical specialists from Brazil tagged as investigators in clinical trials studying Neoplasms, Plasma Cell
Total 14 results
-
Angelo MaiolinoSeen in:
- Rio de Janeiro, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Edvan de Queiroz CrusoeSeen in:
- Bahía, Salvador, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
- NCT05714839 (Principal Investigator)
Conditions: -
Edvan Q CrusoeSeen in:
- Bahia, Salvador, CEHON - Centro de Hematologia e Oncologia da Bahia
Trials:- NCT03792620 (Principal Investigator)
Conditions: -
Francisco CordeiroSeen in:
- Curitiba, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Jayr Schmidt FilhoSeen in:
- Sao Paulo, AC Camargo Cancer Center / Fundação Antonio Prudente Liberdade
- Sao Paulo, Fundacao Antonio Prudente - A.C.Camargo Cancer Center
- São Paulo, GSK Investigational Site
Trials:- NCT03589326 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT06104878 (Principal Investigator)
-
Johnny Francisco CamargoSeen in:
- Parana, Curitiba, Hospital Erasto Gaertner
- Paraná, Curitiba, GSK Investigational Site
Trials:- NCT03589326 (Principal Investigator)
- NCT05064358 (Principal Investigator)
-
Laura Maria FogliattoSeen in:
- RIO Grande DO SUL, Porto Alegre, Hospital de Clínicas de Porto Alegre
- Rio Grande Do Sul, Porto Alegre, GSK Investigational Site
Trials:- NCT03589326 (Principal Investigator)
- NCT04484623 (Principal Investigator)
-
Marcelo BellessoSeen in:
- Sao Paulo, IEP - Instituto de Ensino e Pesquisas São Lucas
- São Paulo, GSK Investigational Site
Trials:- NCT04662255 (Principal Investigator)
- NCT04126200 (Principal Investigator)
Conditions: -
Marcelo CapraSeen in:
- Rio Grande Do Sul, Porto Alegre, Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa - Hospital Mae de Deus
- Rio Grande Do Sul, Porto Alegre, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT04484623 (Principal Investigator)
-
Marcelo Eduardo CapraSeen in:
- Rio Grande Do Sul, Porto Alegre, GSK Investigational Site
Trials:- NCT05064358 (Principal Investigator)
Conditions: -
Marcelo Pitombeira de LacerdaSeen in:
- Santa Catarina, Joinville, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Nelson HamerschlakSeen in:
- São Paulo, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
Conditions: -
Vania HungriaSeen in:
- São Paulo, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT05714839 (Principal Investigator)
Conditions: -
Vania Tietsche HungriaSeen in:
- São Paulo, GSK Investigational Site
Trials:- NCT05064358 (Principal Investigator)
Conditions:
Clinical Trials on Neoplasms, Plasma Cell
-
IRCCS Centro di Riferimento Oncologico della BasilicataCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnPlasma Cell Myeloma | Plasma Cell Leukemia in RemissionUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | ISS Stage III Plasma Cell Myeloma | ISS Stage II Plasma Cell Myeloma | ISS Stage I Plasma Cell MyelomaUnited States